A critical evaluation of assays for detecting antibodies to the heparin-PF4 complexFRANCIS, John L.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 3, pp 359-368, issn 0094-6176, 10 p.Article

A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparinGERDSEN, Frank; LUXEMBOURG, Beate; LANGER, Florian et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 6, pp 477-481, issn 0957-5235, 5 p.Article

Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodiesUNTCH, Brian; AHMAD, Sarfraz; MESSMORE, Harry L et al.Thrombosis research. 2002, Vol 106, Num 2, pp 149-156, issn 0049-3848, 8 p.Article

Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopeniaMOUSA, Shaker A; AHMAD, Sarfraz.American journal of hematology. 2007, Vol 82, Num 4, pp 276-282, issn 0361-8609, 7 p.Article

The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysisCARRIER, Marc; KNOLL, Greg A; KOVACS, Michael J et al.Thrombosis research. 2007, Vol 120, Num 2, pp 215-220, issn 0049-3848, 6 p.Article